

News
OPINION: Elon Musk’s transparency about combating mental health is being used as a hit by MSM
Elon Musk’s wide-ranging interview with Don Lemon dropped on various platforms yesterday, and among one of the discussion points was the Tesla CEO’s use of ketamine to fight depression.
“You’ve admitted that you have a ketamine prescription,” Lemon, a former CNN anchor, asked Musk during the interview. “Yeah, yeah, yeah,” Musk replied.
Lemon dug into Musk’s reasoning for using the technique to fight depression. However, Musk seemed less than enthused to talk about his personal use of a doctor-prescribed medicine to fight what he called a “negative chemical state in my brain, depression, I guess.”
Feeling somewhat blindsided by the question, Musk made it clear it seemed like an invasion of personal privacy to ask about his prescriptions.
However, even though Musk was prescribed the treatment by a doctor to fight depression, mainstream media headlines have attacked the CEO for what they are describing as “drug use,” not giving any sort of context about the drugs, their effectiveness, or even the fact that they are prescribed by a doctor.
Instead, several outlets are leaving out key details, and in a culture where headlines are becoming all that people read, it seems misleading, scummy, and extremely wrong to leave out the fact that ketamine is not being used recreationally.
One headline, for example, reads:
“Elon Musk opens up about drug use, claims it helps him in running Tesla.”
The description of the article also reads:
“Elon Musk does not think drug usage will impact his companies, government contracts, or investor relations.”
Notice there is not a single mention of the fact that his “drug use” is prescribed and not recreational.
It is no secret that Musk’s viral clip of a singular puff of a joint that combined both marijuana and tobacco is still one of the highlighted points by many skeptics. In fact, the episode even caused his security clearances to be reviewed by some government agencies.
However, the lack of details in some outlets’ coverage of Musk’s ketamine use would leave the headline readers of the world to conclude that he is using drugs recreationally in an attempt to keep his daily tasks under a manageable state. In reality, Musk said he uses “a small amount once every other week, or something like that.”
Perhaps a hot take here: I think Musk talking about his mental health battle was super awesome and he showed that he combats issues with his mind every day.
With that being said, I feel like he was definitely put on the spot here and there should have been some notice that this… https://t.co/ztj9Vo5GKL
— Joey Klender (@KlenderJoey) March 18, 2024
The coverage from media outlets proves that Musk, who also said that people with depression should consider methods that are alternatives to traditional selective serotonin reuptake inhibitors (SSRI).
Medicine is obviously a case-by-case basis, but as someone who has battled both depression and anxiety for the duration of my 29 years on Earth, it is upsetting to see someone be attacked for using techniques that work for them. This is not a case of a person using recreational drugs to manage day-to-day stress. It is, in Musk’s words, “literally a prescription from a real doctor.”
Elon Musk’s Neuralink and what it means for anxiety and depression
People who have followed Tesla for basically any period of time know that the company is routinely under fire for things like recalls, car accidents, and other things.
However, attacking the company CEO over his mental health battle and the techniques used to combat a mental health condition that is very widespread is a low blow.
In America, we have come a long way in the battle against mental health ailments. Once considered a taboo topic, mental health conditions are generally accepted by society now as regular and routine issue that a lot of people deal with. According to National Institute of Mental Health, more than 50 million Americans deal with some kind of mental health issue. This is roughly one in five adults, and this only accounts for those who actually get help for their issues.
In my opinion, Musk being transparent about his mental health and his strategies to combat it was a huge win, because many people look up to him. It is perfectly okay to not be okay, even when you’re one of the most innovative minds in modern history.
I’d love to hear your thoughts on this matter. Email us at tips@teslarati.com, or you can email me directly at joey@teslarati.com. I’m also on X @KlenderJoey.
Elon Musk
Tesla is stumped on how to engineer this Optimus part, but they’re close

Tesla has been stumped on how to engineer one crucial part of the Optimus bot, but CEO Elon Musk says the company is “on the cusp” of achieving something great with the project.
During the Q3 2025 Earnings Call, Tesla CEO Elon Musk revealed the company is moving closer to a major breakthrough with the Optimus project, and said they are “on the cusp of something really tremendous.”
However, it seems there is one specific portion of the robot that has truly stumped engineers at the company: the hand, fingers, and forearm.
Musk went into great detail about how incredibly complex and amazing the human hand is, highlighting its dexterity and capability, as its ability to perform a wide variety of tasks is especially impressive:
“I don’t want to downplay the difficulty, but it’s an incredibly difficult thing, especially to create a hand that is as dexterous and capable as the human hand, which is incredible. The human hand is an incredible thing. The more you study the human hand, the more incredible you realize it is, and why you need four fingers and a thumb, why the fingers have certain degrees of freedom, why the various muscles are of different strengths, and fingers are of different lengths. It turns out that those are all there for a reason.”
It’s been pretty apparent that Tesla has made massive strides in the Optimus project, especially considering it has been able to walk down hills, learn things like Kung Fu, and even perform service tasks like serving food and drinks.
However, a recent look at a Gen 2.5 version of Optimus posted by Marc Benioff, the CEO of Salesforce, showed that Tesla was likely using mannequin hands until it developed something that was both useful and aesthetically pleasing:
Very likely that these are non-functional to not give away any major details about next-gen Optimus
The hands are amongst the most complex and important parts of the entire project https://t.co/YgoeNjamvI
— TESLARATI (@Teslarati) September 3, 2025
Musk continued on the call last night that the Tesla team was confronted with an “incredibly difficult” challenge from an engineering perspective, and the hands and actuators for that specific part were tough to figure out:
“Making the hand and forearm, because most of the actuators, just like the human hand, the muscles that control your hand are actually primarily in your forearm. The Optimus hand and forearm is an incredibly difficult engineering challenge. I’d say it’s more difficult than the rest of the robot from an electromechanical standpoint. The forearm and hand are more difficult than the entire rest of the robot. But really, in order to have a useful generalized robot, you do need an incredible hand.”
The CEO continued that developing a useful and effective robot was “crucial to the future of the company,” and that he works with Optimus’s design team each Friday night.
News
Elon Musk sets definitive Tesla Cybercab production date and puts a rumor to rest
“The single biggest expansion in production will be the Cybercab, which starts production in Q2 next year.” -Elon Musk

Tesla CEO Elon Musk finally set a definitive date for Tesla Cybercab production and, at the same time, put a substantial rumor regarding the vehicle that has been circulating within the community to rest.
Tesla’s Cybercab was unveiled last October as the company’s two-seater, affordable option that would ultimately be the car used for autonomous travel. It was initially slated for production in late 2025 or early 2026.
Tesla is ramping up its hiring for the Cybercab production team
However, Tesla has finally said it will start production of the Cybercab in Q2 2026, a more concrete date for the company, as it has moved the entire project forward in recent weeks by testing it at the Fremont Test Track and conducting crash safety assessments.
Musk said on the Q3 2025 Earnings Call:
“The single biggest expansion in production will be the Cybercab, which starts production in Q2 next year. That’s really a vehicle that’s optimized for full autonomy. It, in fact, does not have a steering wheel or pedals and is really an enduring optimization on minimizing cost per mile for fully considered cost per mile of operation.”
In that quote, Musk also put a rumor that has been circulating within the community to rest. Some started to speculate whether Cybercab would be sold with a steering wheel and pedals, as many of the elements of the car seemed to hint toward not being exclusively autonomous, including side mirrors being equipped, among other things.
🚨 The 🐐 @JoeTegtmeyer caught this Tesla Cybercab strolling around Giga Texas —
— with a steering wheel?! pic.twitter.com/PUvmpFp3Re
— TESLARATI (@Teslarati) February 24, 2025
It has been interesting to see some consider whether Tesla would sell the vehicle with the elements that would enable human control, especially as there have been a handful of images of the vehicle on company property with a steering wheel spotted.
However, Musk doubled down on the autonomous nature of the Cybercab with this confirmation during the earnings call, something that many investors likely wanted to hear because it was, in a way, a vote of confidence for the company’s path to autonomy.
Investor's Corner
Tesla (TSLA) Q3 2025 earnings: Wall Street’s reactions
Tesla’s third-quarter 2025 results delivered the highest quarterly revenue in company history, and Wall Street analysts are taking notice.

Tesla’s third-quarter 2025 results delivered record quarterly revenues, and Wall Street is taking notice.
The automaker reported $28.1 billion in revenue, topping estimates of $26.4 billion, while non-GAAP EPS landed at $0.50 versus $0.54 expected. Despite the slight earnings miss, Tesla’s free cash flow surged to nearly $4.0 billion and total cash on hand jumped to $41.6 billion, a new high.
The following are some of Wall Street’s reactions to Tesla’s third-quarter results.
Mizuho
Mizuho analyst Vijay Rakesh maintained an “Outperform” rating on Tesla and raised the firm’s price target to $485 from $460 per share, pointing to Tesla’s next-generation autonomy roadmap. “We see 2026E better with stronger FSD traction and deliveries. TSLA is focusing on AI5/HW5 with ~40x gains gen/gen, while ramping Robotaxis and FSD into 2026E–27E.”
Rakesh also highlighted that Mizuho sees Tesla as “well-positioned” to lead “physical AI with Cybercab/FSD traction, humanoid longer term, offset by near-term demand headwinds.”
Wedbush
Wedbush analyst Dan Ives reiterated his “Outperform” rating and $600 price target on Tesla. As per the analyst, “Tesla reported its FY3Q25 results featuring beats on the top-line while missing bottom-line expectations as the company benefitted from a pull-forward in its delivery segment with greater strength across EMEA and APAC while making gradual progress with its autonomous and energy businesses.”
He also pointed to Musk’s upcoming compensation vote as a key inflection point: “We believe it will be approved by a wide margin despite some opposition,” Ives noted. “That will be incremental to keeping Musk as a war-time CEO as the company enters a critical AI expansion phase.”
Baird
Baird analyst Ben Kallo reiterated his “Outperform” rating and $548 per share price target for Tesla following the company’s Q3 2025 earnings results. He praised Tesla’s energy segment for delivering record results.
“Energy demand is particularly high given grid constraints in several regions and a rapid build-out of infrastructure. We expect this piece of the business to capture more attention in the remainder of 2025 and moving into 2026 with the tipping points for longer-term initiatives (Optimus, robotaxi, etc.) more opaque,” Kallo noted.
Deepwater
Meanwhile, Deepwater’s Gene Munster struck a more measured tone. “The September numbers and earnings call were largely uneventful,” Munster said, adding that Tesla’s decision to move cautiously with robotaxis in Austin is the right one.
“Shares of TSLA traded down following Elon’s comment that he remains paranoid about the safety of Robotaxi given any accidents would represent a significant step back in terms of the public’s confidence in the fleet,” he wrote. Munster, however, emphasized that Tesla’s cash position is a major strength: “They have enough cash to will Elon’s vision into reality. It may take a lot longer than many expect, but they’ve got the cash to get there.”
-
Elon Musk6 days ago
SpaceX posts Starship booster feat that’s so nutty, it doesn’t even look real
-
Elon Musk5 days ago
Tesla Full Self-Driving gets an offer to be insured for ‘almost free’
-
News5 days ago
Elon Musk confirms Tesla FSD V14.2 will see widespread rollout
-
News6 days ago
Tesla is adding an interesting feature to its centerscreen in a coming update
-
News1 week ago
Tesla launches new interior option for Model Y
-
News1 week ago
Tesla widens rollout of new Full Self-Driving suite to more owners
-
Elon Musk6 days ago
Tesla CEO Elon Musk’s $1 trillion pay package hits first adversity from proxy firm
-
News4 days ago
Tesla might be doing away with a long-included feature with its vehicles